Cancer news

The latest news in cancer research, health and policy by Cancer Research UK.

We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy. 

Kidney Cancer

Scientists find rare childhood kidney cancer gene fault

Faults in gene called DIS3L2 are linked to an increased risk of a form of childhood kidney cancer, scientists have discovered.

Obesity helps drive kidney cancer cases to record high

The number of cases of kidney cancer diagnosed each year in Great Britain has risen over 9,000 for the first time, new figures from Cancer Research UK show today.

Study identifies common gene fault in kidney cancer

A study, part-funded by Cancer Research UK, has identified a gene that is faulty in one-third of patients with the most common form of kidney cancer.

Protein ‘block’ kills childhood cancer cells

An experimental drug that blocks an essential cell protein could be used to treat Wilms' tumour, a childhood cancer that affects the kidneys.

'Mutant' gene offers new clue to kidney cancer

An important discovery about how a faulty gene leads to kidney cancer could pave the way for new treatments to block kidney cancer growth, a study published today (Monday...

Postponing surgery reduces long term side effects for children with kidney cancer

Children given chemotherapy before surgery to treat the most common form of childhood kidney cancer, called Wilms' tumour, require less treatment and experience fewer long...

Obesity linked to rise in kidney cancer

Kidney cancer is the fastest growing form of the disease in women, according to new statistics revealed by Cancer Research UK.

Pre-surgery chemo boosts Wilms' tumour treatment says study

Children being treated for the most common form of childhood kidney cancer, known as Wilms' tumour, show better treatment results if given chemotherapy before surgery,...

Cancer Research UK expresses 'deep concern' on kidney cancer drug decision

Cancer Research UK is very disappointed with NICE's decision to reject four kidney cancer drugs.

Cancer Research UK drug enters final trials

A cancer drug developed from discoveries made by Cancer Research UK scientists is entering the final stages of clinical trials for renal cell carcinoma, an aggressive form...

Pages